Nitric Oxide System Regulation (eNOS Activation, Vasodilation, Oxidative Stress Reduction) BPC-157 exhibits a profound and complex interaction with the nitric oxide (NO) system, a critical regulator of numerous physiological processes, including vascular tone, blood flow, and inflammation
Functional outcomes at three months were assessed using the modified Rankin Scale (mRS) through univariate and multivariable logistic and ordinal logistic regression
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
No serious adverse events were attributed to the compound